Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000122

Chief Medical Officer sold 2,857 shares at $24.15 ($68,997)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2023-08-10 Sale −2,857 $24.15 $68,997 185,577 I: show line 1 in the form
Open-market sales · 2,857 sh · avg $24.15 · $68,997
Loading xslF345X05/wk-form4_1692047539.xml…